Entrepreneurship Videos

1. Where Organ On Chips Will Add The Most Value In 3–5 Years 5/19/2026

   Panelists emphasized that CROs and CDMOs will be essential to scaling organ on chip adoption, but only if they commit to standardized, commercial execution rather than treating these systems as experimental add ons. As Don Ingber put it plainly, CROs “need to start buying these commercial systems and start scaling” them to make organ on chip studies operationally viable for industry.

2. How Tome Biosciences' Rahul Kakkar Balances Medical Practice, Biotech Leadership, and Venture Capital Advising 5/22/2024

   Rahul Kakkar explains his transition from architecture student to MD and how he maintains a cardiology practice while leading Tome Biosciences, which he co-founded.